Healthcare >> Analyst Interviews >> May 8, 2002

Outlook For Biotechnology: John Rhodes – Deloitte & Touche

JOHN D. RHODES, CPA, is Deloitte & Touche's Managing Partner for Pharmaceuticals and Life Sciences. In this role, he is responsible for the firm's services to pharmaceutical, biotechnology and medical technology and device companies. Mr. Rhodes has significant experience with pharmaceutical, manufacturing and process industries, focusing on accounting and auditing, SEC reporting, business process and contracting issues, corporate compliance, strategic alliances, research and promotion collaborations, joint venture formations and mergers and acquisitions. He has published in Pharmaceutical Executive and has co-authored firm publications on the Life Sciences industry. He is a member of the firm's Manufacturing Industry Operating Committee. Profile
TWST: What are the current fundamentals that underlie merger and

acquisition activity versus what they were six to 12 months ago?

Mr. Rhodes: The forces today have evolved from six months